As filed with the Securities and Exchange Commission on February 12, 2002
Registration No. 333-49567
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1 TO
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
COR THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE 94-3060271
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
(617) 679-7000
(Address, including zip code, and telephone
number, including area code, of principal executive offices)
1998 NON-OFFICER EQUITY INCENTIVE PLAN
(Full Title of the Plan)
JOHN B. DOUGLAS III, ESQ.
PRESIDENT
COR THERAPEUTICS, INC.
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
(Name and Address of Agent For Service)
(617) 679-7000
(Telephone Number, Including Area Code, of Agent For Service)
-----------------------------
Copy to:
David E. Redlick, Esq.
Hale and Dorr LLP
60 State Street
Boston, Massachusetts 02109
Telephone: (617) 526-6000
Telecopy: (617) 526-5000
DEREGISTRATION OF COMMON STOCK
On April 7, 1998, COR Therapeutics, Inc. ("COR") filed a
Registration Statement on Form S-8, Registration No. 333-49567 (the
"Registration Statement"), for the sale of 600,000 shares (as adjusted to
give effect to a two-for-one stock split effected on August 15, 2000) of COR
Common Stock, $.0001 par value per share (the "Common Stock"), under the COR
Therapeutics, Inc. 1998 Non-Officer Equity Incentive Plan (the "Plan"). On
February 12, 2002, pursuant to the terms of an Agreement and Plan of Merger,
dated as of December 5, 2001 (the "Merger Agreement"), by and among
Millennium Pharmaceuticals, Inc. ("Millennium"), PGM Corporation, a wholly
owed subsidiary of Millennium, and COR, PGM Corporation merged with and into
COR and COR became a wholly owned subsidiary of Millennium. Pursuant to the
Merger Agreement, Millennium assumed the Plan and the obligations of COR
under the Plan. This Post-Effective Amendment No. 1 to the Registration
Statement is being filed to deregister all of the unsold shares of Common
Stock formerly issuable under the Plan and registered under the Registration
Statement, constituting 83,786 shares.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant has duly caused this Post-Effective Amendment No. 1 to Form S-8 to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City
of Cambridge, Commonwealth of Massachusetts, on this 12th day of February, 2002.
COR THERAPEUTICS, INC.
By: /S/ JOHN B. DOUGLAS III
---------------------------------
John B. Douglas III
President and Director
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment has been signed by the following persons in the
capacities and on the dates indicated.
SIGNATURE TITLE DATE
--------- ----- -----
/S/ JOHN B. DOUGLAS III President and Director February 12, 2002
- ------------------------ (Principal Executive Officer)
John B. Douglas III
/S/ KEVIN P. STARR Treasurer and Director February 12, 2002
- ----------------------- (Principal Financial and
Kevin P. Starr Accounting Officer)
/S/ MARK J. LEVIN Director February 12, 2002
- ----------------------
Mark J. Levin